Kenneth R. Meehan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kenneth R. Meehan has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
John M. Hill
Transplant and Cellular Therapy Program, Section of Hematology, Dartmouth-Hitchcock Medical Center , the Dartmouth Cancer Center
4 shared publicationsChristi Ann Hayes
Transplant and Cellular Therapy Program, Section of Hematology, Dartmouth-Hitchcock Medical Center , the Dartmouth Cancer Center
3 shared publicationsKate L. Caldon
Transplant and Cellular Therapy Program, Section of Hematology, Dartmouth-Hitchcock Medical Center , the Dartmouth Cancer Center
3 shared publicationsLinda Patchett
2 shared publicationsTor D. Tosteson
2 shared publicationsAnna N. A. Tosteson
1 shared publication
Latest Publications
- 4 September 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (12) , 1047.e1-1047.e12
The Clinical Utility of Real-Time Patient-Reported Outcomes in Cell Therapy Recipients
- 4 September 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (12) , 1047.e1-1047.e12
The Clinical Utility of Real-Time Patient-Reported Outcomes in Cell Therapy Recipients
- 1 April 2024
- Published by HMP Communications, LLC in Journal of Clinical Pathways
- Vol. 10 (2)
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
Background: Patient-reported outcome measures (PROMs) offer a collaborative opportunity between the patient and the care team to improve the quality of care. Objectives: To define PROMs in patients receiving hematopoietic stem cell transplant (HSCT), a pre-visit questionnaire (PVQ) was developed, which included a single agenda-setting question, the PROMIS-29 survey, and the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT). Study Design: Patients completed the PVQ 1 month prior to transplant (baseline) and at 1, 3, 6, and 12 months following transplant. Results: Sixty-five patients (n = 27 allogenic; n = 38 autologous) participated. Survey completion rates were 95% at 1 month post-transplant, 74% at 6 months, and 65% at one year. One month following transplant, patients’ fatigue (P < .001) increased, while physical (P < .001) and social (P < .001) functions decreased. Each returned to baseline at 3 months (P < .001). Fatigue was more pronounced in allogeneic recipients (P = .017) and autologous recipients recovered physical function much sooner (P = .021). Conclusions: This study confirms the feasibility of capturing PROMs longitudinally in patients receiving HSCT and demonstrates significant changes in fatigue and physical and social functioning following transplant.
- 1 April 2024
- Published by HMP Communications, LLC in Journal of Clinical Pathways
- Vol. 10 (2)
Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results
Background: Patient-reported outcome measures (PROMs) offer a collaborative opportunity between the patient and the care team to improve the quality of care. Objectives: To define PROMs in patients receiving hematopoietic stem cell transplant (HSCT), a pre-visit questionnaire (PVQ) was developed, which included a single agenda-setting question, the PROMIS-29 survey, and the National Comprehensive Cancer Network (NCCN) Distress Thermometer (DT). Study Design: Patients completed the PVQ 1 month prior to transplant (baseline) and at 1, 3, 6, and 12 months following transplant. Results: Sixty-five patients (n = 27 allogenic; n = 38 autologous) participated. Survey completion rates were 95% at 1 month post-transplant, 74% at 6 months, and 65% at one year. One month following transplant, patients’ fatigue (P < .001) increased, while physical (P < .001) and social (P < .001) functions decreased. Each returned to baseline at 3 months (P < .001). Fatigue was more pronounced in allogeneic recipients (P = .017) and autologous recipients recovered physical function much sooner (P = .021). Conclusions: This study confirms the feasibility of capturing PROMs longitudinally in patients receiving HSCT and demonstrates significant changes in fatigue and physical and social functioning following transplant.
- Open Access
- 1 September 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (9) , e227-e231
Caregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center
- 1 September 2020
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (9) , e227-e231
Open AccessCaregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center
- 11 February 2016
- Published by Wiley in Transfusion
- Vol. 56 (5) , 1082-1087
Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed?
The majority of PLT transfusions (95%) were appropriate, and only 5% were avoidable. If the prophylactic PLT transfusion threshold was decreased to 15 × 10(9) /L from 20 × 10(9) /L for central line removal and to fulfill discharge PLT count criteria, 41% of the currently appropriate PLT transfusions could have been avoided. These results suggest that a risk-adapted method to select autologous transplant recipients for prophylactic PLT transfusions may be beneficial. A future study is needed to address this issue.
- 11 February 2016
- Published by Wiley in Transfusion
- Vol. 56 (5) , 1082-1087
Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed?
The majority of PLT transfusions (95%) were appropriate, and only 5% were avoidable. If the prophylactic PLT transfusion threshold was decreased to 15 × 10(9) /L from 20 × 10(9) /L for central line removal and to fulfill discharge PLT count criteria, 41% of the currently appropriate PLT transfusions could have been avoided. These results suggest that a risk-adapted method to select autologous transplant recipients for prophylactic PLT transfusions may be beneficial. A future study is needed to address this issue.
- Open Access
- 1 January 2013
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 19 (1) , 129-137
Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma
- 1 January 2013
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 19 (1) , 129-137
Open AccessAdoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma
- 1 April 2006
- Vol. 4 (4) , 187-90
The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients.
This study is a prospective evaluation of the time commitment and financial requirements of caregivers of autologous stem cell recipients during the period of inpatient hospitalization. Eligible patients identified one caregiver, and a one-page survey addressing the necessary time commitment and out-of-pocket expenses was completed by the caregiver at each visit. The caregivers of 40 patients participated (non-Hodgkin's lymphoma [n = 19], multiple myeloma [n = 18], Hodgkin's lymphoma [n = 2], or acute myelogenous leukemia [n = 1]). Caregivers included spouses (n = 35), partners/friends (n = 2), or family members (n = 3). Results were summarized for the patient's total length of stay. Each caregiver traveled a median of 829 miles over 17.8 hours. Out-of-pocket expenses varied greatly depending on whether a caregiver stayed in local accommodations (cohort 1; n = 11) or in the patient's hospital room (cohort 2; n = 29). Total expenses (median) for each caregiver in cohort 1 were dollar 849.35, including accommodations (dollar 560), gasoline (dollar 87.35), and food (dollar 202). Total expenses (median) for each caregiver in cohort 2 were dollar 181.15, including gasoline (dollar 70) and food (dollar 111.15). Each caregiver in cohort 1 lost a median of 43.5 hours of work compared with 8 hours for each caregiver in cohort 2. The results from this prospective study demonstrate that there is a significant financial and time requirement on the part of the caregiver when a family member or significant other is hospitalized for an autologous stem cell transplant.
- 1 April 2006
- Vol. 4 (4) , 187-90
The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients.
This study is a prospective evaluation of the time commitment and financial requirements of caregivers of autologous stem cell recipients during the period of inpatient hospitalization. Eligible patients identified one caregiver, and a one-page survey addressing the necessary time commitment and out-of-pocket expenses was completed by the caregiver at each visit. The caregivers of 40 patients participated (non-Hodgkin's lymphoma [n = 19], multiple myeloma [n = 18], Hodgkin's lymphoma [n = 2], or acute myelogenous leukemia [n = 1]). Caregivers included spouses (n = 35), partners/friends (n = 2), or family members (n = 3). Results were summarized for the patient's total length of stay. Each caregiver traveled a median of 829 miles over 17.8 hours. Out-of-pocket expenses varied greatly depending on whether a caregiver stayed in local accommodations (cohort 1; n = 11) or in the patient's hospital room (cohort 2; n = 29). Total expenses (median) for each caregiver in cohort 1 were dollar 849.35, including accommodations (dollar 560), gasoline (dollar 87.35), and food (dollar 202). Total expenses (median) for each caregiver in cohort 2 were dollar 181.15, including gasoline (dollar 70) and food (dollar 111.15). Each caregiver in cohort 1 lost a median of 43.5 hours of work compared with 8 hours for each caregiver in cohort 2. The results from this prospective study demonstrate that there is a significant financial and time requirement on the part of the caregiver when a family member or significant other is hospitalized for an autologous stem cell transplant.
- 27 February 2006
- Published by Wiley in Transfusion
- Vol. 46 (4) , 523-529
Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization
- 27 February 2006
- Published by Wiley in Transfusion
- Vol. 46 (4) , 523-529
Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization
- 1 January 2006
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 26 (10) , 593-601
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.
- 1 January 2006
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 26 (10) , 593-601
Resource utilisation and time commitment associated with correction of anaemia in cancer patients using epoetin alfa.